Hosted on MSN1d
Axon Stock Looks To Continue Triple-Digit Run As It Nears A Buy Point
In addition to its close-range Taser energy weapons, Axon makes body and fleet cameras, along with drones and evidence management software. Its equipment is used by law enforcemen ...
The Lancet2d
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease
Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...
S&P 500's TJX, IBD Stock Of The Day, Doesn't Care About Trump Tariffs. It's Near A Buy Point.
Stock Of The Day: S&P 500 component TJX advanced toward an early buy point Tuesday, after testing its 50-day line Monday.
Colorectal cancer: Detection of early symptoms and prevention
Colorectal cancer is becoming a significant public health issue in India, especially among individuals under 50 years old.
The Lancet3d
Applying the estimand framework to inflammatory bowel disease clinical trials
Since the first, seminal randomised controlled trial (RCT) in inflammatory bowel disease (IBD) in 1955,1 the central tenets for high-quality clinical trials have been recognised as robust and ...
Netflix, IBD Stock Of The Day, Hovers In Buy Zone After Q4 Beat
Netflix is the IBD Stock Of The Day as the subscription streaming video leader hovers in the buy zone of its post-earnings ...